Follow
Luis Ortega-Paz
Luis Ortega-Paz
University of Florida College of Medicine-Jacksonville
Verified email at jax.ufl.edu
Title
Cited by
Cited by
Year
Coronavirus disease 2019–associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management
L Ortega‐Paz, D Capodanno, G Montalescot, DJ Angiolillo
Journal of the American Heart Association 10 (3), e019650, 2021
1732021
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events …
L Ortega-Paz, D Capodanno, T Gori, H Nef, A Latib, G Caramanno, CM Di, ...
EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2017
1322017
Pre-eclampsia/eclampsia and hepatic rupture
P Vigil-De Gracia, L Ortega-Paz
International Journal of Gynecology & Obstetrics 118 (3), 186-189, 2012
992012
Magnesium-based resorbable scaffold versus permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: the MAGSTEMI randomized …
M Sabate, F Alfonso, A Cequier, S Romani, P Bordes, A Serra, A Iniguez, ...
Circulation 140 (23), 1904-1916, 2019
822019
Retinal detachment in association with pre-eclampsia, eclampsia, and HELLP syndrome
P Vigil-De Gracia, L Ortega-Paz
International Journal of Gynecology & Obstetrics 114 (3), 223-225, 2011
752011
Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis
A Mompeón, L Ortega-Paz, X Vidal-Gómez, TJ Costa, D Pérez-Cremades, ...
Scientific reports 10 (1), 5373, 2020
742020
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis …
L Ortega-Paz, M Galli, D Capodanno, F Franchi, F Rollini, B Bikdeli, ...
European Heart Journal-Cardiovascular Pharmacotherapy 8 (7), 677-686, 2022
602022
Effects of ticagrelor, prasugrel, or clopidogrel on endothelial function and other vascular biomarkers: a randomized crossover study
S Ariotti, L Ortega-Paz, M van Leeuwen, S Brugaletta, S Leonardi, ...
JACC: Cardiovascular Interventions 11 (16), 1576-1586, 2018
562018
Conocimientos y actitudes acerca de la investigación científica en los estudiantes de medicina de la Universidad de Panamá
SAS Villarreal, JZ Cisneros, CO Loubon, A Yau, F Castro, JMB Castro, ...
Archivos de medicina 9 (3), 1, 2013
512013
Adenosine and ticagrelor plasma levels in patients with and without ticagrelor-related dyspnea
L Ortega-Paz, S Brugaletta, S Ariotti, KM Akkerhuis, A Karagiannis, ...
Circulation 138 (6), 646-648, 2018
392018
10-Year follow-up of patients with everolimus-eluting versus bare-metal stents after ST-segment elevation myocardial infarction
S Brugaletta, J Gomez-Lara, L Ortega-Paz, V Jimenez-Diaz, M Jimenez, ...
Journal of the American College of Cardiology 77 (9), 1165-1178, 2021
372021
Acute and chronic effects of COVID-19 on the cardiovascular system
V Arévalos, L Ortega-Paz, JJ Rodríguez-Arias, M Calvo Lopez, ...
Journal of Cardiovascular Development and Disease 8 (10), 128, 2021
312021
Capacitación en investigación brindada a los estudiantes de medicina de la facultad de medicina de la Universidad de Panamá.
C Ortega-Loubon, J Zúñiga-Cisneros, F Castro, JM Barría-Castro, ...
Archivos de medicina 9 (3), 2013
312013
Amphilimus-vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial
R Romaguera, P Salinas, J Gomez-Lara, S Brugaletta, ...
European Heart Journal 43 (13), 1320-1330, 2022
302022
Long-term coronary functional assessment of the infarct-related artery treated with everolimus-eluting bioresorbable scaffolds or everolimus-eluting metallic stents: insights …
J Gomez-Lara, S Brugaletta, L Ortega-Paz, B Vandeloo, E Moscarella, ...
JACC: Cardiovascular Interventions 11 (16), 1559-1571, 2018
272018
Impact of body mass index on 5-year clinical outcomes in patients with ST–segment elevation myocardial infarction after everolimus-eluting or bare-metal stent implantation
E Moscarella, G Spitaleri, S Brugaletta, SS Farrarons, A Pernigotti, ...
The American journal of cardiology 120 (9), 1460-1466, 2017
252017
Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention
M Galli, L Ortega-Paz, F Franchi, F Rollini, DJ Angiolillo
Pharmacogenomics 23 (13), 723-737, 2022
242022
Five-Year Optical Coherence Tomography in Patients With ST-Segment–Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents
J Gomez-Lara, S Brugaletta, F Jacobi, L Ortega-Paz, M Ñato, G Roura, ...
Circulation: Cardiovascular Interventions 9 (10), e003670, 2016
242016
Management of heart failure with reduced ejection fraction after ESC 2016 heart failure guidelines: the Linx Registry
F de Frutos, S Mirabet, L Ortega‐Paz, I Buera, S Darnés, N Farré, B Perez, ...
ESC heart failure 7 (1), 26-36, 2020
212020
ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a …
S Brugaletta, T Gori, AF Low, P Tousek, E Pinar, J Gomez-Lara, ...
International journal of cardiology 214, 483-484, 2016
212016
The system can't perform the operation now. Try again later.
Articles 1–20